Showing results (1501-1510 of 2,037) with videos related to
Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|May 1, 1979
Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexesC Schümichen, M Hohloch, G HoffmannNuklearmedizin. Nuclear Medicine|May 22, 2010
[99mTc reduces clonogenic survival after intracellular uptake in NIS-positive cells in vitro more than 131I]M Wendisch, R Freudenberg, J Drechsel, et al.Nuklearmedizin. Nuclear Medicine|October 16, 2010
Myocardial perfusion alterations observed months after radiotherapy are related to the cellular damageI Dogan, O Sezen, B Sonmez, et al.Nuklearmedizin. Nuclear Medicine|September 30, 2010
Recombinant human TSH versus hypothyroidism. Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinomaM Dietlein, S Busemeyer, C Kobe, et al.Nuklearmedizin. Nuclear Medicine|February 1, 1991
Biokinetics and estimation of dose from 99mTc-labelled polyclonal human immunoglobulin (HIG)A Saptogino, W Becker, F WolfNuklearmedizin. Nuclear Medicine|February 1, 1991
[The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?]M L Sautter-Bihl, H Bihl, H G HeinzeNuklearmedizin. Nuclear Medicine|November 9, 2010
Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphomaA Grgic, U Nestle, K Scheidhauer, et al.Nuklearmedizin. Nuclear Medicine|January 20, 2011
Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?S Kang, B-C Ahn, C M Hong, et al.Nuklearmedizin. Nuclear Medicine|December 15, 2010
[Radiation effect in normal tissue - principles of damage and protection]W DörrNuklearmedizin. Nuclear Medicine|December 15, 2010
[Metabolic micromilieu in tumours]W Mueller-KlieserPageof 204